Human coagulation factor Ⅷ /Human von Willebrand factor (Shandong Taibang Biological Products)

人凝血因子Ⅷ（山东泰邦）/人血管性血友病因子（山东泰邦生物制品）

Report date: 2025/07/18 15:24:54

Base Information

Drug NameHuman coagulation factor Ⅷ /Human von Willebrand factor (Shandong Taibang Biological Products)
Drug Alias Name人凝血因子Ⅷ/血管性血友病因子复合物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation +[5] 
TargetsCoagulation factor XCoagulation factor VIII
Therapy Area/IndicationsAcquired hemophiliavon Willebrand Disease, Type 1von Willebrand Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Human coagulation factor Ⅷ (Shandong Taibang)Human von Willebrand factor (Shandong Taibang Biological Products)
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShandong Taibang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsAcquired hemophiliavon Willebrand Disease, Type 1von Willebrand Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A